Sagitta Pharma accelerates its development plan with the acquisition of the R3S-Pharmasmile Group

Supported by Isatis Capital since 2021, Sagitta Pharma - a key player in the distribution of healthcare products in France - is accelerating its growth and strengthening its position in the South-West of France through the acquisition of the R3S-Pharmasmile group.

Comprising the companies R3S and Pharmasmile, founded in 2016 and 2018 respectively, the group has quickly established itself as one of the leading pharmaceutical distribution players in the Nouvelle-Aquitaine region. With a catalog of over 10,000 product references, the group has, in just a few years, gained the trust of more than 500 pharmacies, which rely on its daily delivery service, operating six days a week. To ensure high-quality service and strengthen its proximity to clients, the group operates a logistics platform of over 3,000 square meters dedicated to order preparation and dispatch.

This transaction marks a significant milestone in Sagitta Pharma’s development strategy within a region that has remained largely untapped by the Group. The merger will also enable R3S-Pharmasmile’s clients to benefit from Sagitta Pharma’s purchasing hub offering, while streamlining the Group’s logistics operations with a view to enhancing customer service.

With this acquisition, Sagitta Pharma is now working with over 2,500 pharmacies across France and aims to become the leading independent distributor in the country.

“I am very pleased to welcome Mathilde, Cédric, and their teams to Sagitta Pharma. Our shared entrepreneurial values and passion for the pharmacy profession are what brought us together. We are now well-positioned to strengthen our presence in the French market through a unique service offering, accelerate our growth, and support our fellow pharmacists in their daily practice, helping them rise to the new challenges facing the profession.”

Jérôme Brunet, President of Sagitta Pharma

“For several years, the Sagitta Pharma Group has experienced strong organic growth. Today, this external growth represents a key milestone for the Group; it significantly strengthens its territorial coverage and enables it to offer its high value-added services to more than 500 additional pharmacies. The newly formed entity is expected to quickly surpass €200 million in revenue and become a leading player in its market.”

Laurent Baudino, Managing Partner at Isatis Capital

Companies

• Sagitta Pharma: Jérôme Brunet
• R3S: Cédric Drapier
• Pharmasmile : Mathilde Dupin

Investors

• Isatis Capital : Laurent Baudino, Séverin Lefaure
• BNP Paribas Développement : Frédéric Connault

Buyer's Advisors

• Legal Advisor : Lamartine Conseil
• Financial Advisor : Advance Capital

Sellers' Advisors

• Financial Advisor: Concorde

Founded in 2009 by Jérôme Brunet, Sagitta Pharma is a healthcare products distribution group (including reimbursed medicines, OTC drugs, and pharmaceutical products), operating as both a pharmaceutical purchasing hub and a full-line wholesaler across nearly 60 French departments.

The Group’s value proposition lies in the breadth of its product catalog (over 18,000 items) and the flexibility of its offering, which is tailored to individual pharmacists and pharmacy networks (more than 2,000 clients). This is made possible through a digital ordering platform, including white-label solutions.

More information: www.sagittapharma.com

Isatis Capital is an independent management company that has been investing in equity for over 20 years, working alongside ambitious entrepreneurs to accelerate the growth of their SMEs. As a long-term investor, Isatis Capital takes either minority or majority stakes and provides strategic support to foster business development.

A signatory of the United Nations Global Compact, the Initiative Climat International (iCi), and a member of the Task Force on Climate-Related Financial Disclosures (TCFD), Isatis Capital is strongly committed to ESG principles, both in its operations and investment activities.

The company manages €480 million in assets across several funds dedicated to institutional clients, as well as those distributed through private banks and independent financial advisors.

• Isatis Capital : Laurent Baudino – Phone : +33 6 33 48 03 92 – Mail : laurent.baudino@isatis-capital.fr